Skip to main content
Veterinary Medicines

Zobuxa 50 mg tablets for cats and dogs

Authorised
  • Enrofloxacin

Product identification

Medicine name:
Zobuxa 50 mg tablets for cats and dogs
Zobuxa 50 mg Tabletten für Katzen und Hunde
Active substance:
  • Enrofloxacin
Target species:
  • Dog
  • Cat
Route of administration:
  • Oral use

Product details

Active substance and strength:
  • Enrofloxacin
    50.00
    milligram(s)
    /
    1.00
    Tablet
Pharmaceutical form:
  • Tablet
Withdrawal period by route of administration:
  • Oral use
    • Dog
    • Cat
Anatomical therapeutic chemical veterinary (ATCvet) codes:
  • QJ01MA90
Authorisation status:
  • Valid
Authorised in:
  • Austria
Available in:
  • Austria
Package description:
  • (ID1) 10 Tablet: unspecified outer container with 1 Blister (Aluminium) with 10 Tablet
  • (ID2) 100 Tablet: unspecified outer container with 1 Blister (Aluminium) with 100 Tablet

Additional information

Entitlement type:
  • Marketing Authorisation
Marketing authorisation holder:
  • Elanco GmbH
Marketing authorisation date:
Manufacturing sites for batch release:
  • Elanco France S.A.S
Responsible authority:
  • Austrian Agency For Health And Food Safety
Authorisation number:
  • 8-01007
Date of authorisation status change:
Reference member state:
  • Germany
Procedure number:
  • DE/V/0197/002
Concerned member states:
  • Austria
  • Czechia
  • Hungary
  • Ireland
  • Italy
  • Poland
  • Portugal
  • Slovakia
  • Slovenia
  • United Kingdom (Northern Ireland)

Documents

Summary of Product Characteristics

English (PDF)
Published on: 16/02/2022
Download
German (PDF)
Published on: 4/03/2019

Package Leaflet

This document does not exist in this language (English). You can find it in another language below.
German (PDF)
Published on: 4/03/2019

Labelling

This document does not exist in this language (English). You can find it in another language below.
German (PDF)
Published on: 4/03/2019
How useful was this page?:
No votes yet
"Please do not include any personal data, such as your name or contact details. If you do, you consent to the processing of that data in accordance with EMA’s Privacy Statement concerning requests for information or access to documents. If you would like a reply from EMA, please Send a question to EMA instead."